The person that brought that to your attention has a point but I'll make this point- how often is it you see a little biotech in Australia that provides a more effective and safer drug than the current standard of care? Not just once but so far it looks like PD1 will do the same. There is definitely a paradigm shift happening and it's all pointing our way.While yes, 1.5 billion market cap seems a lot for a company not producing something but when the potential is billions of sales per year, we are on the right track. We have been hinted at that deal(s) aren't far away, whether that's licensing or T/O.
And don't even get me started on CF33.
-
- There are more pages in this discussion • 2,540 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.010(3.57%) |
Mkt cap ! $77.89M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 26.5¢ | $407.7K | 1.508M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 623451 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 66358 | 4 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |